ALLAKOS INC (ALLK) Stock Price, Quote, News and Overview
NASDAQ:ALLK - Nasdaq - US01671P1003 - Common Stock - Currency: USD
ALLK Quote, Performance and Key Statistics
ALLAKOS INC
NASDAQ:ALLK (2/4/2025, 8:26:12 PM)
Premarket: 0.2502 0 (-0.83%)0.2523
+0.01 (+3.11%)
The current stock price of ALLK is 0.2523 USD. In the past month the price decreased by -78.25%. In the past year, price decreased by -81.17%.
ALLK Latest News, Press Releases and Analysis
On Friday, there are stocks with unusual volume. Let's take a look.
The trading volume of these stocks is deviating from the norm in today's session.
The trading volume of these stocks is deviating from the norm in today's session.
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the stocks with an unusual volume in today's session.
Get insights into the top gainers and losers of Tuesday's pre-market session.
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Which stocks are experiencing notable movement on Monday?
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.
Deal Dispatch: Sage And Silvus Are Up For Sale, MrBeast Secures $20B For TikTok
Sage Therapeutics rejects Biogen deal offer; Silvus Technologies considers sale/IPO; Allakos downsizes; MrBeast bids on TikTok.
Allakos Stock Craters To Record Low On Lead Drug Setback: Retail Hopes Fade
The disappointing results prompted Allakos to terminate AK006-related programs across all functions and implement a 75% workforce reduction.
ALLK Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.77 | 335.67B | ||
| AMGN | AMGEN INC | 14.58 | 155.36B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 945.65 | 124.20B | ||
| GILD | GILEAD SCIENCES INC | 22.12 | 122.12B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.27 | 76.60B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.95B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 34.95B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.08B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.76B | ||
| NTRA | NATERA INC | N/A | 23.00B | ||
| BIIB | BIOGEN INC | 8.73 | 20.76B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.52 | 15.78B |
Related stock screener links
About ALLK
Company Profile
Allakos, Inc. engages in the development of therapeutic antibodies. The company is headquartered in San Carlos, California and currently employs 131 full-time employees. The company went IPO on 2018-07-19. The Company’s most advanced product candidate, AK006, is in a Phase I clinical trial. AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. The company is developing AK006 for the treatment of CSU and potentially other indications. AK006 has completed preclinical testing, and in these studies, it has demonstrated that binding of AK006 to Siglec-6 inhibits multiple modes of mast cell activation, including IgE, IL-33, KIT, C5a and MRGPR-X2. In addition to mast cell inhibition, AK006 reduced human tissue mast cells via ADCP in the presence of activated macrophages. The firm is also developing lirentelimab (AK002) and, in conjunction with the Phase II, lirentelimab results in atopic dermatitis and chronic spontaneous urticaria.
Company Info
ALLAKOS INC
825 Industrial Road, Suite 500
San Carlos CALIFORNIA 94065 US
CEO: Robert Alexander
Employees: 131
Company Website: https://www.allakos.com/
Investor Relations: https://investor.allakos.com/
Phone: 16505975002
ALLK FAQ
What is the stock price of ALLK?
The current stock price of ALLK is 0.2523 USD.
What is the symbol for ALLAKOS INC stock?
The exchange symbol of ALLAKOS INC is ALLK and it is listed on the Nasdaq exchange.
On which exchange is ALLK stock listed?
ALLK stock is listed on the Nasdaq exchange.
Is ALLK a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ALLK, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ALLK.
Does ALLK stock pay dividends?
ALLK does not pay a dividend.
What is the Price/Earnings (PE) ratio of ALLK?
ALLK does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.03).
What is the Short Interest ratio of ALLK stock?
The outstanding short interest for ALLK is 1.05% of its float.
ALLK Technical Analysis
ALLK Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALLK. The financial health of ALLK is average, but there are quite some concerns on its profitability.
ALLK Financial Highlights
Over the last trailing twelve months ALLK reported a non-GAAP Earnings per Share(EPS) of -2.03. The EPS decreased by -5.73% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -143.65% | ||
| ROE | -245.72% | ||
| Debt/Equity | 0 |
ALLK Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 74% to ALLK. The Buy consensus is the average rating of analysts ratings from 13 analysts.